Skip to main content

Outage notice:

Due to the global information outage that occurred this morning, Quest is taking swift action to respond, recover and restore our operations. Our Patient Services are operating with reduced capacity so you may experience longer wait and service times. Our Customer Contact teams are currently unavailable. We appreciate your patience as we work toward returning to normal operations. 

Hide

The CDC Clinical Practice Guideline for Prescribing Opiods for Pain

The CDC Clinical Practice Guideline for Prescribing Opiods for Pain

Click here to listen

EPISODE SUMMARY

Welcome to the Quest Diagnostics “topics in drug testing” podcast. Today’s episode is with Quest Diagnostics senior medical advisor, Dr Jeff Gudin, and Dr Jack Kain, director and medical science liaison for the Quest Drug Monitoring and Toxicology business.

The podcast will cover:

  • Summary of the 2022 CDC Clinical Practice Guideline for Prescribing Opioids
    for Pain
  • Summary of key findings from the Quest Diagnostics Health Trends report,
    Drug Misuse in America 2022—A Decade Lost to the Drug Crisis

 

Presenters: Jeff Gudin, MD, Sr Medical Advisor and Jack Kain PharmD, Medical Science Liasion

Published: April 7, 2023

 

To listen to other podcasts in our Topics in Drug Testing series on Podbean.com, please visit QuestDrugTesting.com.

At Quest Diagnostics, we are committed to providing you results and insight to support your clinical decisions.